$VWAV News: VisionWave Holdings Establishes Israeli

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
241
$VWAV News: VisionWave Holdings Establishes Israeli Subsidiary and Appoints Leadership Team to Advance Strategic Technology Platform

VisionWave Holdings, Inc.
Fri, March 20, 2026 at 8:00 AM EDT 4 min read

WEST HOLLYWOOD, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a developer of advanced AI-driven sensing, RF, and defense-related technologies, today announced the establishment and full acquisition of VisionWave IL Ltd., a wholly owned subsidiary based in Israel for nominal consideration.

The Company has appointed Khdoura Sabbagh (A/K/A Adir Sabag) as Chief Executive Officer and sole director of VisionWave IL Ltd., and engaged Oren Attiya, through CO-Finance Financial and Accounting Consulting Ltd., to provide financial leadership and CFO-level services to the subsidiary.

Strategic Expansion into Israel - The formation of VisionWave IL Ltd. represents an initial step in the Company’s continued expansion of its global operational footprint, positioning VisionWave within one of the world’s leading hubs for advanced engineering, defense innovation, and applied AI technologies.

Israel is widely recognized for its concentration of high-caliber engineering talent, particularly in areas directly aligned with VisionWave’s core platforms, including:

RF-based sensing and signal intelligence

Autonomous systems and defense technologies

Advanced data processing and AI-driven applications

VisionWave believes that establishing a dedicated presence in Israel will support its ability to accelerate development initiatives, strengthen technical capabilities, and enhance execution across its growing portfolio of strategic programs. This remains subject to successful implementation, talent acquisition, and market conditions, and there can be no assurance that the subsidiary will generate material benefits or revenue in the near term.

Leadership Appointments – Adir Sabag, as CEO of VisionWave IL Ltd., will lead the subsidiary’s operations, including business development, engineering coordination, and local execution of strategic initiatives.

Oren Attiya, through his consulting firm, will support the subsidiary’s financial infrastructure, including accounting, reporting, and compliance functions, contributing to the Company’s ongoing commitment to disciplined financial oversight.

Management Commentary -Douglas Davis, CEO and Executive Chairman of VisionWave Holdings, stated:

“The establishment of VisionWave IL Ltd. reflects our continued focus on building a globally integrated technology platform. Israel represents a unique environment with advanced engineering, defense expertise, and innovation converge. We believe this expansion strengthens our ability to execute on multiple strategic initiatives across our platform.”

Positioning Within VisionWave’s Broader Strategy

The Israeli subsidiary is expected to support the Company’s broader initiatives across its evolving technology ecosystem, including:

RF-based sensing and imaging technologies

Autonomous and unmanned system applications

Defense and homeland security-related platforms

Integration of advanced computational and AI-driven capabilities

VisionWave believes that this expansion may enhance its ability to align technical development with commercial and strategic opportunities across multiple regions. Any benefits remain subject to execution risks, including regulatory, geopolitical, and operational factors in Israel.

About VisionWave Holdings, Inc.

VisionWave Holdings, Inc. (Nasdaq: VWAV) is a dual-market autonomous systems platform company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave’s mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and sea.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the establishment of VisionWave IL Ltd., the appointments of leadership, the potential benefits of an Israeli presence, expected support for development initiatives, and the Company’s broader strategic opportunities in defense and autonomy technologies. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially.

Forward-looking statements are generally identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "project," "forecast," "predict," and similar expressions, or by statements that events or trends "may," "will," or "could" occur.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including but not limited to: the early-stage and exploratory nature of the subsidiary with no assurance of material contributions; challenges in talent acquisition, operational execution, or strategic alignment in Israel; geopolitical, regulatory, or economic risks associated with operations in Israel; potential delays or failures in realizing any anticipated benefits from the subsidiary; the Company’s ability to fund and manage international expansion without significant impact on liquidity; competition in defense and autonomy technologies; and other risks described in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release and in the Company's SEC filings. VisionWave undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contacts:

VWAV - Investor Contact: investors@vwav.inc

Website: https://www.vwav.inc
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading